The Inspire ANTI SNORING Implant is a medical device that’s implanted into the body for the treating snoring and obstructive anti snoring (OSA) syndrome.

Obstructive Sleep Apnea Syndrome

Obstructive anti snoring syndrome is a disease caused by relapsing episodes of sleep apnea. It is a condition where breathing stops for more than 10 seconds, where oxygen saturation in the blood is reduced by more than 4%.

OSA syndrome occurs while asleep, when the muscles of upper airways relax, evoking the obstruction of the respiratory tract. This results in deterioration of blood oxygenation and provokes short unconscious wake-up episodes throughout the night. An unhealthy pattern of sleep places stress on the body, causing increased blood circulation pressure and development of severe diseases. The diseases caused by OSA could be physical, such as hypertension, myocardium infarction and stroke. They could also be mental, including depression, chronic fatigue syndrome, lack of memory and concentration.

Before any treatment, a sleep study or a polysomnography is needed. The polysomnography calculates the apnea index, that is the frequency of apnea episodes during 1 hour of sleep and determines the severe nature of the condition. The apnea index is considered significant if there are more than 20 apnea episodes per hour, regardless of the presence or lack of clinical symptoms.

The gold standard of treatment for OSA syndrome is CPAP-therapy. However, CPAP therapy isn’t for everyone as many folks think it is uncomfortable to sleep with the mask on the facial skin and the device itself can be loud, especially since it commonly sits near the head. Only 25% of patients may use CPAP-therapy for a long period of time.

Therefore, recently Inspire Medical Systems Inc. has think of a very effective solution with the Inspire ANTI SNORING Implant.

How The Inspire Sleep Apnea Implant Works

The Inspire ANTI SNORING Implant is really a battery operated device that promotes electrostimulation of the sublingual nerve. The battery life is approximately 10 years.

The main unit of the device is placed under the skin, on the front right side of the chest also it monitors the phase of breathing. Another electrode is implanted for stimulation of the sublingual nerve, which creates muscle tension. This opens top of the airways and allows the tongue to stand out, and helps keep the airways open while asleep.

In addition to the two electrodes, this device also contains a handy small remote switch, that actually turns on the device before sleep and switches it off once awake. This disables the electrodes from disturbing the processes of communication and eating during the active phase of your day, when a person needs physiological narrowing of the larynx and tongue movements for these processes.

The patient may feel light involuntary contractions of the larynx, or tongue movements during initial use of these devices. These movements usually do not cause pain, instead only a minor discomfort. These unpleasant effects disappear following the first few uses of these devices.

Generally, the implant ought to be checked 1 or 2 2 times each year. However, depending on situation, an Inspire therapy-trained doctor may consult patients pretty much often.

The Inspire Sleep Apnea Implant is only ideal for:

Patients who are more than 22 years old.
Patients who have been diagnosed with moderate or severe obstructive anti snoring syndrome.
Patients with an apnea index in the number of 20 to 65.
Patients who are uncomfortable with using CPAP therapy or didn’t have the desired effect.
Patients with a body mass index of less than 32.
Body mass index (BMI) = weight (kg) / height^2 (m2).
An individual with a weight of 80 kg and a height of 170 cm has

BMI = 80kg / (1.7m ^ 2) = 80 / 2.89 = 27.68 kg/ m2

The Inspire Sleep Apnea Implant could potentially replace CPAP therapy as ‘the gold standard’ of treatment for obstructive anti snoring syndrome. A report by Dr. Ryan J. et al. shows that after implantation of the Inspire Sleep Apnea Implant, snoring is greatly decreased. A share of “no” or “soft” snoring changed from 22% at start of the treatment to 88% at 12 months and 91% at two years after the treatment. Also, the apnea index was reduced from 31 to 14. 82% of the patients in the study reported a nightly usage of this therapy for five years. Therefore, it really is evident that method is impressive and easy to use! ufabet

Leave a Reply

Your email address will not be published. Required fields are marked *